FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/19/2025
Back to search
Official data from USPTO
TAVEREN THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TAVEREN THERAPEUTICS
ST13
US500000079383216Class
5, 42
Filing
79383216
Registration
7691277
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 42
Filing date
09/12/2023
Registration date
02/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
CZ
Examiner
MORRIS, KRISTINA KLOIBER
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
I. S. (pessoa física)
Representatives
Jason J. Mazur ArentFox Schiff LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical drugs for treatment of oncological diseases; chemical preparations for medical purposes for treatment of oncological diseases; diagnostic substances for medical use; chemical preparations for pharmaceutical purposes for treatment of oncological diseases; adjuvants for medical purposes; diagnostic preparations for medical purposes; pharmaceutical compositions for treatment of oncological diseases; biological preparations for use in cell cultures for medical purposes.
Class 42
Research and development for the pharmaceutical industry; development of pharmaceutical preparations and medicines; medical research in the field of oncology; medical research in the field of neurobiology; chemical analysis; analytical laboratory servicesresearch laboratory analysis services in the field of biochemistry; biochemistry research services; chemistry serviceschemical synthesis; advisory services relating to research and development of pharmaceutical drugs; science and technology servicesscientific research; technological consultancy in the field of treatment of oncological diseases; scientific laboratory services; conducting early evaluations in the field of new pharmaceuticals
Publications
History of USPTO decisions and trademark events.
26 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/11/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/31/2025
FIMP
FINAL DISPOSITION PROCESSED
08/31/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/18/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/15/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/15/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/18/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2024
PUBO
PUBLISHED FOR OPPOSITION
12/31/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2024
RFNT
REFUSAL PROCESSED BY IB
06/23/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2024
RFRR
REFUSAL PROCESSED BY MPU
06/06/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/04/2024
CNRT
NON-FINAL ACTION WRITTEN
05/16/2024
DOCK
ASSIGNED TO EXAMINER
05/07/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/16/2023
Continuous trademark protection
Get notified about every new filing that threatens TAVEREN THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.